Skip to main content
. 2019 Dec 6;2019(1):158–166. doi: 10.1182/hematology.2019000023

Table 6.

Ongoing studies for the secondary prevention of CAT in adult patients

Study Study design Intervention Status
Apixaban in Preventing Secondary Cancer-Related Blood Clots in Cancer Patients Who Have Completed Anticoagulation Therapy (NCT03080883) RCT Lower-dose apixaban vs higher-dose apixaban Recruiting
API-CAT STUDY for APIxaban Cancer-Associated Thrombosis (API-CAT; NCT03692065) RCT Apixaban 2.5 mg twice daily vs 5 mg twice daily Recruiting